Press Releases

Industry Research Finds Two-Thirds of Clinical Data Managers and CRAs Believe Current Inefficiencies Put Data Quality at Future Risk

ClearNote Health Receives In Vitro Diagnostic Approval in United Kingdom for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

ClearNote Health Receives UKCA markings for Avantect® Multi-Cancer Detection Test and Avantect® Ovarian Cancer Test

Takara Bio Europe Launches Cellartis® MSC EV Wonder™, a Defined, Xeno-Free Medium for High-Yield EV Production

Takara Bio Europe announces the launch of Cellartis® MSC EV Wonder.

MIB Agents Now Accepting Letters of Intent for Annual OutSmarting Osteosarcoma Research Grants

Nonprofit Awards Grants to Projects Focused on Moving Research Forward for Rare Bone Cancer Patients

Certara Launches DIDB® Concomitant Meds Navigator, Extending Leadership in Drug Interaction Science

Certara on Sept. 22 launched a new capability in its Drug Interaction Database (DIDB) - the pharmaceutical industry’s largest scientist-curated collection of human in vitro and clinical data used to assess drug-drug interactions (DDIs) and safety - that allows researchers to rapidly identify medications that could impact a drug’s effects when taken together, allowing for safer and more intentional drug development.

Huateng Pharma Provides Key Intermediate for Phase 3 Drug Candidate Aficamten

Hunan Huateng Pharmaceutical Co., Ltd. provides 1-Methyl-1H-Pyrazole-4-Carboxylic Acid (CAS 5952-92-1), a high-purity intermediate used in the synthesis of Aficamten (CK-274), an investigational cardiac myosin inhibitor currently in Phase 3 trials for hypertrophic cardiomyopathy.

LabConnect Partners with The Bracken Group to Expand Radiopharmaceutical Support Services

LabConnect has announced a strategic collaboration with The Bracken Group to expand its radiopharmaceutical support services, addressing fast-growing demand in the field. The partnership combines LabConnect’s global operational expertise with Bracken’s scientific and regulatory leadership, strengthening support for biotech and pharmaceutical companies developing targeted therapies and diagnostics. Together, the organizations aim to enhance capabilities in logistics, sample processing, and scientific oversight for complex radiopharmaceutical trials.

Carolina Molecular Inc. and Astoriom to Collaborate on Integrated Molecular Testing and Biospecimen Storage Services

Research Triangle Park-based companies provide comprehensive testing and sample storage to CROs, CDMOs, Pharma and Biotech Partners

Arkivum announces new partnership with unified trial management platform provider PHARMASEAL

Arkivum is delighted to announce a new partnership with PHARMASEAL, the provider of the Engility® Trial Management Platform, consisting of a Clinical Trial Management System (CTMS) and Electronic Trial Master File (eTMF).

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

Lindus Health and Frieda Health Successfully Complete Clinical Trial Evaluating Novel Treatment for Menopause Symptoms

electronRx to Launch pDx App for Remote Chronic Respiratory Disease Management

● Technology detects digital biomarkers to help monitor lung function and optimise therapeutic outcomes for patients ● electronRx to showcase pDx at HLTH 2025 (19–22 Oct, Las Vegas)

LabConnect and OmniScience to Deliver First Agentic AI Solution for Real-Time Clinical Trial Lab Insights

LabConnect and OmniScience have a strategic collaboration to launch the first AI-powered solution for real-time clinical trial lab data insights, streamlining fragmented lab datasets and automating oversight for trial sponsors. Their collaboration centers on OmniScience’s Vivo platform, which provides instant analysis and actionable intelligence from complex laboratory data to accelerate trial timelines and improve outcomes. Both companies aim to revolutionize clinical development by integrating LabConnect’s lab expertise with OmniScience’s AI-native approach, boosting efficiency and supporting faster delivery of life-changing therapies.

Advarra launches AI- and data-backed study design solution to improve operational efficiency in clinical trials

Next-Gen IRB Review Is Here: WCG ClinSphere™ eReview Manager Drives Transformative Efficiencies, Accelerates Clinical Research

WCG announced the launch of WCG ClinSphere™ eReview Manager, a breakthrough solution purpose-built to simplify Institutional Review Board (IRB) submission and review processes. As the market leader in speed, agility, and quality, this addition to the WCG ClinSphere technology platform streamlines workflows, enhances real-time collaboration, and ensures the highest quality reviews — all within a single, modern, and intuitive user interface.

Abzena Enhances AbZelectPRO™ Cell Line Offering with New GS Knockout Platforms

UMass Signed a Non-Exclusive License Agreement with Hongene

UMass Chan Medical School has signed a non-exclusive license agreement with Hongene Biotech to produce exNA-modified oligonucleotides, a breakthrough in RNA therapeutics that improves drug stability and opens new doors for advanced research.

PhaseV & Bioforum Partner on AI Clinical Trial Optimization

DNAnexus and Oracle Join Forces to Deliver Genomic Insights at the Point of Care

Collaboration to enable healthcare professionals to access and interpret genomic data alongside patient medical history.

VieCure and N-Power Medicine Partner to Transform Precision Medicine and Clinical Trial Access in Community Oncology

N-Power Medicine and VieCure announced a strategic partnership that will enable more community oncology practices to incorporate cutting-edge research into patient treatment plans while delivering precision medicine insights directly at the point of care.

One2Treat raises capital to further accelerate software platform development and relocates offices to support rapid growth

One2Treat SA, a fast-growing technology company transforming how the patient voice is integrated into clinical development, announced today the successful completion of a planned seed extension to accelerate its software platform development.